Total Covid-19 vaccine doses given in India crosses 155.28 crore

The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers (HCWs) getting inoculated in the first phase

A health worker administers a dose of Covid-19 vaccine to a visitor at a vaccination centre in Kolkata on October 22, 2021. (PTI Photo/ Swapan Mahapatra)
Representational image
Press Trust of India New Delhi
2 min read Last Updated : Jan 14 2022 | 2:10 AM IST

The cumulative COVID-19 vaccine doses administered in the country crossed 155.28 crore on Thursday with more than 63 lakh doses being given till 7 pm, the Union Health Ministry said.

More than 33,12,573 precaution doses have been administered so far to healthcare workers, frontline workers and those aged 60 and above with comorbidities.

Also, 3,12,89,109 first doses have been given to beneficiaries in the 15-18 years age group so far.

Till 7 pm on Thursday, 63,92,572 vaccine doses were administered. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late night.

The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers (HCWs) getting inoculated in the first phase. The vaccination of frontline workers (FLWs) started from February 2 last year.

The next phase of COVID-19 vaccination commenced from March 1, 2021 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.

Vaccination for all people aged more than 45 years began from April 1, 2021. The government then decided to expand its drive by allowing everyone above 18 to be vaccinated from May 1 last year.

The next phase of COVID-19 vaccination commenced from January 3 this year for adolescents in the age group of 15-18 years.

India began administering precaution dose of COVID-19 vaccine to healthcare workers, frontline workers including personnel deployed for election duty and those aged 60 and above with comorbidities from January 10 amid the country witnessing a spike in coronavirus infections fuelled by Omicron variant of the virus.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Jan 14 2022 | 2:10 AM IST

Next Story